[Fibromyalgia, where are we in 2023 ?]

Abstract

Fibromyalgia remains a nebulous clinical entity for many practitioners. Actually, this pathology associates diffuse chronic pain with a host of somatic complaints, which may be variable from one patient to another. The difficulty resides also in establishing the diagnosis, which remains essentially clinical, in the absence of anatomical lesions, as well as biological or anatomopathological anomalies. Patients are usually confronted to a therapeutic wandering phase, of variable duration, before being recognized in their pathology. Management of fibromyalgia has to be multimodal, including physiotherapy, a cognitive-behavioural approach, and an individually tailored medical support.